Initial Stage Affects Survival Even After Complete Pathologic Remission is Achieved in Locally Advanced Esophageal Cancer: Analysis of 70 Patients With Pathologic Major Response After Preoperative Chemoradiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 1, 2009, Pages 115-121

  Kim, Min Kyoung ^a,b   Cho, Kyung Ja ^a   Park, Seung Il ^a   Kim, Yong Hee ^a   Kim, Jong Hoon ^a   Song, Ho Young ^a   Shin, Ji Hoon ^a   Jung, Hwoon Yong ^a   Lee, Gin Hyug ^a   Choi, Kee Don ^a   Song, Ho June ^a   Ryu, Jin Sook ^a   Kim, Sung Bae ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

Author keywords

Combined modality therapy; Esophageal neoplasm; Pathologic complete response; Prognosis

Indexed keywords

CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; ESOPHAGEAL CANCER; ESOPHAGEAL CARCINOMA; ESOPHAGEAL NEOPLASM; INDEPENDENT PREDICTORS; INITIAL STAGES; MULTI VARIATE ANALYSIS; OVERALL SURVIVAL; PATHOLOGIC COMPLETE RESPONSE; PATHOLOGIC COMPLETE RESPONSE (PCR); PATHOLOGIC RESPONSE; PRE-TREATMENT; PROGNOSIS; RECURRENCE-FREE SURVIVAL; RESIDUAL DISEASE;

DECISION MAKING; FLUORESCENT SCREENS; TELEVISION PICTURE TUBES; TUMORS;

MULTIVARIANT ANALYSIS;

CAPECITABINE; CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TREATMENT RESPONSE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; REMISSION INDUCTION; SURVIVAL ANALYSIS;

EID: 68649095893     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.074     Document Type: Article

References (25)

1. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
2. Bosset J.F., Gignoux M., Triboulet J.P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337 (1997) 161-167
3. Burmeister B.H., Smithers B.M., Gebski V., et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial. Lancet Oncol 6 (2005) 659-668
4. Iyer R., Wilkinson N., Demmy T., et al. Controversies in the multimodality management of locally advanced esophageal cancer: Evidence-based review of surgery alone and combined-modality therapy. Ann Surg Oncol 11 (2004) 665-673
5. Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
6. Kim S.B. Esophageal cancer; multimodality approach. [abstract]. Cancer Res Treatment 35 Suppl 2 (2003) 44
7. Lee J.L., Kim S.B., Jung H.Y., et al. Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma-a single institutional study. Acta Oncol 42 (2003) 207-217
8. Kim S.B., Park S.I., Kim J.H., et al. A phase II trial of preoperative one cycle of induction chemotherapy [capecitibine (CAP), CDDP] followed by concurrent chemoradiation (CRT) in patients (pts) with resectable esophageal cancer. [abstract]. J Clin Oncol 23 Suppl (2005) 4063a
9. Lee J.L., Park S.I., Kim S.B., et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 15 (2004) 947-954
10. Kim M.K., Kim S.B., Ahn J.H., et al. Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 71 (2008) 725-734
11. Berger A.C., Farma J., Scott W.J., et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 23 (2005) 4330-4337
12. Chirieac L.R., Swisher S.G., Ajani J.A., et al. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103 (2005) 1347-1355
13. Wu T.T., Chirieac L.R., Abraham S.C., et al. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: A reliable predictor for patient outcome. Am J Surg Pathol 31 (2007) 58-64
14. Schneider P.M., Baldus S.E., Metzger R., et al. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: Implications for response classification. Ann Surg 242 (2005) 684-692
15. Reynolds J.V., Muldoon C., Hollywood D., et al. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg 245 (2007) 707-716
16. Rizk N.P., Venkatraman E., Bains M.S., et al. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol 25 (2007) 507-512
17. Song S.Y., Kim J.H., Ryu J.S., et al. FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1053-1059
18. American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. (2002), Lippincott-Raven, Philadelphia p. 91-98
19. Rohatgi P., Swisher S.G., Correa A.M., et al. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104 (2005) 2365-2372
20. Kato H., Miyazaki T., Nakajima M., et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer 103 (2005) 148-156
21. Chang E.Y., Smith C.A., Corless C.L., et al. Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer. Am J Surg 193 (2007) 614-617
22. Mandard A.M., Dalibard F., Mandard J.C., et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73 (1994) 2680-2686
23. Swisher S.G., Hofstetter W., Wu T.T., et al. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241 (2005) 810-817
24. Junker K., Thomas M., Schulmann K., et al. Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J Cancer Res Clin Oncol 123 (1997) 469-477
25. Hidaka H., Hotokezaka M., Nakashima S., et al. Sex difference in survival of patients treated by surgical resection for esophageal cancer. World J Surg 31 (2007) 1982-1987